PMC:7253233 / 1453-1832 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"74","span":{"begin":210,"end":218},"obj":"Species"},{"id":"81","span":{"begin":37,"end":45},"obj":"Disease"},{"id":"82","span":{"begin":96,"end":116},"obj":"Disease"},{"id":"83","span":{"begin":175,"end":196},"obj":"Disease"},{"id":"84","span":{"begin":238,"end":246},"obj":"Disease"},{"id":"85","span":{"begin":311,"end":324},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"Tax:9606"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:D012640"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"MESH:D001927"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"MESH:D009422"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"MESH:C000657245"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:D009102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":311,"end":316},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":311,"end":316},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":102,"end":116},"obj":"Disease"},{"id":"T16","span":{"begin":238,"end":246},"obj":"Disease"},{"id":"T17","span":{"begin":298,"end":324},"obj":"Disease"},{"id":"T18","span":{"begin":359,"end":371},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005560"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0043726"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":311,"end":316},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":37,"end":45},"obj":"Phenotype"},{"id":"T13","span":{"begin":96,"end":116},"obj":"Phenotype"},{"id":"T14","span":{"begin":359,"end":371},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0006846"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"not electrographically monitored for seizures due to limited resources, multifactorial risk for acute encephalopathy, and the risk of cross-contamination. Previously, several neurological symptoms were seen in patients with more advanced COVID-19 disease, and these were thought to be secondary to multi-system organ failure and/or disseminated intravascular coagulopathy-related"}